IMU 2.88% 5.4¢ imugene limited

Ann: Investor Webinar - Final HER-Vaxx Overall Survival Results, page-6

  1. 585 Posts.
    lightbulb Created with Sketch. 5011
    Quick takeaways from webinar ...

    • HER-Vaxx is now PROVED with significant p-values
    • Trial was very solid
    • Lesley, when asked specifically "Data better than I anticipated'. This is amazing as she was very positive prior - even more so now.
    • Delighted that they can now dose at 100 This has her exuberant. This may improve results even further!!!
    • The treatment is SAFE SAFE SAFE
    • Treatment so much easier for patients - "like a vaccine" - They have it and can just go home.
    • IMU will not look to move to expensive Ph3 trial but continue with combined trials.

    More later.

    Looking good my IMU friends

 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.4¢
Change
0.002(2.88%)
Mkt cap ! $382.1M
Open High Low Value Volume
5.2¢ 5.4¢ 5.2¢ $220.3K 4.167M

Buyers (Bids)

No. Vol. Price($)
17 933996 5.3¢
 

Sellers (Offers)

Price($) Vol. No.
5.4¢ 3426188 18
View Market Depth
Last trade - 13.21pm 21/08/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.